Abstract
Impaired beta adrenoceptor-mediated vasodilation associated with enhanced sympathetic activity has been reported in established hypertension. We examined whether altered beta adrenoceptor-mediated vasodilation occurs early in the disease process, when structural vascular changes are likely to be less marked, by measurement of forearm blood flow by strain gauge plethysmography after the intraarterial administration of increasing doses of a beta receptor agonist, isoproterenol, in eight subjects with borderline hypertension (BHT) and 13 normotensive (NT) controls. To determine the role of sympathetic activation in the regulation of responsiveness, we measured local sympathetic activity in the forearm by a radioisotope dilution technique. Vasodilation in response to isoproterenol, measured either as changes in forearm blood flow or forearm vascular resistance, was impaired in the BHT group so that flow at the highest dose of isoproterenol (400 ng/min) increased less (15.2 +/- 1.5 ml/100 ml per min) than in the NT group (24.4 +/- 2.4 ml/100 ml per minute) (P < 0.001). Although, systemic norepinephrine spillover was significantly greater in BHT, the difference in blood flow response to isoproterenol was not accounted for by increased local sympathetic activity since forearm norepinephrine spillover at baseline (BHT 1.0 +/- 0.4 ng/min vs. NT 0.64 +/- 0.13 ng/min) and after the administration of isoproterenol 60 ng/min (BHT 5.2 +/- 1.4 ng/min vs. NT 6.0 +/- 1.5 ng/min) and 400 ng/min (BHT 13.5 +/- 2.9 ng/min vs. NT 16.5 +/- 2.7 ng/min) did not differ between the two groups. We therefore conclude that vasodilation in response to isoproterenol is impaired in subjects with BHT and that this impairment is not explained by locally increased basal, or stimulated, sympathetic activity.
Full text
PDF![579](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/baab/185232/a09839ff34e7/jcinvest00013-0595.png)
![580](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/baab/185232/0da43a0da868/jcinvest00013-0596.png)
![581](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/baab/185232/a16a3711820d/jcinvest00013-0597.png)
![582](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/baab/185232/4a680c06d6e4/jcinvest00013-0598.png)
![583](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/baab/185232/6f1ab46d7bd4/jcinvest00013-0599.png)
![584](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/baab/185232/1ec1fac27dff/jcinvest00013-0600.png)
![585](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/baab/185232/5fb09f2e94a9/jcinvest00013-0601.png)
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Anderson E. A., Sinkey C. A., Lawton W. J., Mark A. L. Elevated sympathetic nerve activity in borderline hypertensive humans. Evidence from direct intraneural recordings. Hypertension. 1989 Aug;14(2):177–183. doi: 10.1161/01.hyp.14.2.177. [DOI] [PubMed] [Google Scholar]
- Bertel O., Bühler F. R., Kiowski W., Lütold B. E. Decreased Beta-adrenoreceptor responsiveness as related to age, blood pressure, and plasma catecholamines in patients with essential hypertension. Hypertension. 1980 Mar-Apr;2(2):130–138. doi: 10.1161/01.hyp.2.2.130. [DOI] [PubMed] [Google Scholar]
- Chang P. C., Kriek E., van Brummelen P. Sympathetic activity and presynaptic adrenoceptor function in patients with longstanding essential hypertension. J Hypertens. 1994 Feb;12(2):179–190. [PubMed] [Google Scholar]
- Chang P. C., Kriek E., van der Krogt J. A., van Brummelen P. Does regional norepinephrine spillover represent local sympathetic activity? Hypertension. 1991 Jul;18(1):56–66. doi: 10.1161/01.hyp.18.1.56. [DOI] [PubMed] [Google Scholar]
- Cockcroft J. R., Chowienczyk P. J., Benjamin N., Ritter J. M. Preserved endothelium-dependent vasodilatation in patients with essential hypertension. N Engl J Med. 1994 Apr 14;330(15):1036–1040. doi: 10.1056/NEJM199404143301502. [DOI] [PubMed] [Google Scholar]
- Egan B., Panis R., Hinderliter A., Schork N., Julius S. Mechanism of increased alpha adrenergic vasoconstriction in human essential hypertension. J Clin Invest. 1987 Sep;80(3):812–817. doi: 10.1172/JCI113138. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Eichler H. G., Ford G. A., Blaschke T. F., Swislocki A., Hoffman B. B. Responsiveness of superficial hand veins to phenylephrine in essential hypertension. Alpha adrenergic blockade during prazosin therapy. J Clin Invest. 1989 Jan;83(1):108–112. doi: 10.1172/JCI113845. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Esler M., Jackman G., Bobik A., Leonard P., Kelleher D., Skews H., Jennings G., Korner P. Norepinephrine kinetics in essential hypertension. Defective neuronal uptake of norepinephrine in some patients. Hypertension. 1981 Mar-Apr;3(2):149–156. doi: 10.1161/01.hyp.3.2.149. [DOI] [PubMed] [Google Scholar]
- Esler M., Jennings G., Korner P., Blombery P., Sacharias N., Leonard P. Measurement of total and organ-specific norepinephrine kinetics in humans. Am J Physiol. 1984 Jul;247(1 Pt 1):E21–E28. doi: 10.1152/ajpendo.1984.247.1.E21. [DOI] [PubMed] [Google Scholar]
- Feldman R. D. Defective venous beta-adrenergic response in borderline hypertensive subjects is corrected by a low sodium diet. J Clin Invest. 1990 Mar;85(3):647–652. doi: 10.1172/JCI114487. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Feldman R. D., Limbird L. E., Nadeau J., Robertson D., Wood A. J. Leukocyte beta-receptor alterations in hypertensive subjects. J Clin Invest. 1984 Mar;73(3):648–653. doi: 10.1172/JCI111255. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fraser J., Nadeau J., Robertson D., Wood A. J. Regulation of human leukocyte beta receptors by endogenous catecholamines: relationship of leukocyte beta receptor density to the cardiac sensitivity to isoproterenol. J Clin Invest. 1981 Jun;67(6):1777–1784. doi: 10.1172/JCI110217. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Furchgott R. F., Vanhoutte P. M. Endothelium-derived relaxing and contracting factors. FASEB J. 1989 Jul;3(9):2007–2018. [PubMed] [Google Scholar]
- Goldstein D. S. Plasma catecholamines and essential hypertension. An analytical review. Hypertension. 1983 Jan-Feb;5(1):86–99. doi: 10.1161/01.hyp.5.1.86. [DOI] [PubMed] [Google Scholar]
- Goldstein D. S., Zimlichman R., Stull R., Folio J., Levinson P. D., Keiser H. R., Kopin I. J. Measurement of regional neuronal removal of norepinephrine in man. J Clin Invest. 1985 Jul;76(1):15–21. doi: 10.1172/JCI111939. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gordon T., Kannel W. B. Obesity and cardiovascular diseases: the Framingham study. Clin Endocrinol Metab. 1976 Jul;5(2):367–375. doi: 10.1016/s0300-595x(76)80026-6. [DOI] [PubMed] [Google Scholar]
- Gray D. W., Marshall I. Novel signal transduction pathway mediating endothelium-dependent beta-adrenoceptor vasorelaxation in rat thoracic aorta. Br J Pharmacol. 1992 Nov;107(3):684–690. doi: 10.1111/j.1476-5381.1992.tb14507.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Harden T. K. Agonist-induced desensitization of the beta-adrenergic receptor-linked adenylate cyclase. Pharmacol Rev. 1983 Mar;35(1):5–32. [PubMed] [Google Scholar]
- Hausdorff W. P., Caron M. G., Lefkowitz R. J. Turning off the signal: desensitization of beta-adrenergic receptor function. FASEB J. 1990 Aug;4(11):2881–2889. [PubMed] [Google Scholar]
- He H. B., Deegan R. J., Wood M., Wood A. J. Optimization of high-performance liquid chromatographic assay for catecholamines. Determination of optimal mobile phase composition and elimination of species-dependent differences in extraction recovery of 3,4-dihydroxybenzylamine. J Chromatogr. 1992 Feb 14;574(2):213–218. [PubMed] [Google Scholar]
- Ikezono K., Zerkowski H. R., Beckeringh J. J., Michel M. C., Brodde O. E. Beta-2 adrenoceptor-mediated relaxation of the isolated human saphenous vein. J Pharmacol Exp Ther. 1987 Apr;241(1):294–299. [PubMed] [Google Scholar]
- Leenen F. H., Boer P., Dorhout Mees E. J. Peripheral beta-adrenoceptor responsiveness in young normotensive and hypertensive subjects. Clin Exp Hypertens. 1981;3(3):539–553. doi: 10.3109/10641968109033681. [DOI] [PubMed] [Google Scholar]
- Lertora J. J., Mark A. L., Johannsen J., Wilson W. R., Abboud F. M. Selective beta-1 receptor blockade with oral practolol in man. A dose-related phenomenon. J Clin Invest. 1975 Sep;56(3):719–724. doi: 10.1172/JCI108143. [DOI] [PMC free article] [PubMed] [Google Scholar]
- McAllister R. G., Jr, Love D. W., Guthrie G. P., Jr, Dominic J. A., Kotchen T. A. Peripheral beta-receptor responsiveness in patients with essential hypertension. Arch Intern Med. 1979 Aug;139(8):879–881. [PubMed] [Google Scholar]
- Naslund T., Silberstein D. J., Merrell W. J., Nadeau J. H., Wood A. J. Low sodium intake corrects abnormality in beta-receptor-mediated arterial vasodilation in patients with hypertension: correlation with beta-receptor function in vitro. Clin Pharmacol Ther. 1990 Jul;48(1):87–95. doi: 10.1038/clpt.1990.121. [DOI] [PubMed] [Google Scholar]
- Panza J. A., Quyyumi A. A., Brush J. E., Jr, Epstein S. E. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med. 1990 Jul 5;323(1):22–27. doi: 10.1056/NEJM199007053230105. [DOI] [PubMed] [Google Scholar]
- Pedrinelli R., Panarace G., Salvetti A. Calcium entry blockade and adrenergic vascular reactivity in hypertensives: differences between nicardipine and diltiazem. Clin Pharmacol Ther. 1991 Jan;49(1):86–93. doi: 10.1038/clpt.1991.14. [DOI] [PubMed] [Google Scholar]
- Scherrer U., Randin D., Tappy L., Vollenweider P., Jéquier E., Nicod P. Body fat and sympathetic nerve activity in healthy subjects. Circulation. 1994 Jun;89(6):2634–2640. doi: 10.1161/01.cir.89.6.2634. [DOI] [PubMed] [Google Scholar]
- Shore A. C., Tooke J. E. Microvascular function in human essential hypertension. J Hypertens. 1994 Jul;12(7):717–728. [PubMed] [Google Scholar]
- Stein M., Deegan R., He H., Wood A. J. Beta-adrenergic receptor-mediated release of norepinephrine in the human forearm. Clin Pharmacol Ther. 1993 Jul;54(1):58–64. doi: 10.1038/clpt.1993.110. [DOI] [PubMed] [Google Scholar]
- Stein M., Deegan R., Wood A. J. Long-term exposure to beta 2-receptor agonist specifically desensitizes beta-receptor-mediated venodilation. Clin Pharmacol Ther. 1993 Aug;54(2):187–193. doi: 10.1038/clpt.1993.130. [DOI] [PubMed] [Google Scholar]
- Taddei S., Virdis A., Mattei P., Salvetti A. Vasodilation to acetylcholine in primary and secondary forms of human hypertension. Hypertension. 1993 Jun;21(6 Pt 2):929–933. doi: 10.1161/01.hyp.21.6.929. [DOI] [PubMed] [Google Scholar]
- Takeshita A., Mark A. L. Structural vascular changes in young patients with borderline hypertension. Jpn Circ J. 1983 Feb;47(2):256–257. doi: 10.1253/jcj.47.256. [DOI] [PubMed] [Google Scholar]
- WHITNEY R. J. The measurement of volume changes in human limbs. J Physiol. 1953 Jul;121(1):1–27. doi: 10.1113/jphysiol.1953.sp004926. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Watson R. D., Esler M. D., Leonard P., Korner P. I. Influence of variation in dietary sodium intake on biochemical indices of sympathetic activity in normal man. Clin Exp Pharmacol Physiol. 1984 Mar-Apr;11(2):163–170. doi: 10.1111/j.1440-1681.1984.tb00253.x. [DOI] [PubMed] [Google Scholar]